Xiaodong Wei

机构：Red Cross Hospital, University of Hong Kong · ORCID：0000-0003-0080-0035

发表论文 65 篇 · 总被引 1123 次 · h-index 20

代表论文

• RSL3 enhances the antitumor effect of cisplatin on prostate cancer cells via causing glycolysis dysfunction (2021 · Biochemical Pharmacology · 被引 62)
• Recent advances in natural phthalides: Distribution, chemistry, and biological activities (2022 · Fitoterapia · 被引 56)
• Sources of gut microbiota variation in a large longitudinal Finnish infant cohort (2023 · EBioMedicine · 被引 45)
• In-duct grating-like dielectric barrier discharge system for air disinfection (2022 · Journal of Hazardous Materials · 被引 41)
• RSL3 triggers glioma stem cell differentiation via the Tgm2/AKT/ID1 signaling axis (2022 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 被引 38)
• A Combination of BRD4 and HDAC3 Inhibitors Synergistically Suppresses Glioma Stem Cell Growth by Blocking GLI1/IL6/STAT3 Signaling Axis (2020 · Molecular Cancer Therapeutics · 被引 32)